Time to burn? Endoscopic ablation for Barrett's esophagus

Gastroenterology

Volumn 141, Issue 2, 2011, Pages 417-419

  Inadomi, John M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; COST EFFECTIVENESS ANALYSIS; DYSPLASIA; ENDOSCOPY; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; FOLLOW UP; HUMAN; INTESTINE METAPLASIA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; TREATMENT FAILURE;

EID: 80051516328     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.025     Document Type: Editorial

References (16)

1. N.J. Shaheen, P. Sharma, and B.F. Overholt Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
2. N.J. Shaheen, B.F. Overholt, and R.E. Sampliner Durability of radiofrequency ablation in Barrett's esophagus with dysplasia Gastroenterology 141 2011 460 468
3. D.E. Fleischer, B.F. Overholt, and V.K. Sharma Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial Endoscopy 42 2010 781 789
4. V.K. Sharma, H. Jae Kim, and A. Das Circumferential and focal ablation of Barrett's esophagus containing dysplasia Am J Gastroenterol 104 2009 310 317
5. B.J. Reid, P.L. Blount, and P.S. Rabinovitch Biomarkers in Barrett's esophagus Gastrointest Endosc Clin North Am 13 2003 369 397 (Pubitemid 36605251)
6. L.M. Merlo, N.A. Shah, and X. Li A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma Cancer Prev Res (Phila) 3 2010 1388 1397
7. J.H. Rubenstein, N. Vakil, and J.M. Inadomi The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma Aliment Pharmacol Ther 22 2005 135 146 (Pubitemid 41039702)
8. V. Namasivayam, K.K. Wang, and G.A. Prasad Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions Clin Gastroenterol Hepatol 8 2010 743 754
9. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640 (Pubitemid 34173814)
10. D.J. Kearney, C. Crump, and C. Maynard A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD Gastrointest Endosc 57 2003 823 829 (Pubitemid 47243609)
11. J.H. Rubenstein, A. Sonnenberg, and J. Davis Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 2008 849 855
12. J.M. Inadomi, M. Somsouk, and R.D. Madanick A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 2009 2101 2114
13. P. Sharma Low-grade dysplasia in Barrett's esophagus Gastroenterology 127 2004 1233 1238 (Pubitemid 39345891)
14. R.H. Riddell, and R.D. Odze Definition of Barrett's esophagus: time for a rethinkis intestinal metaplasia dead? Am J Gastroenterol 104 2009 2588 2594
15. J.H. Rubenstein, J.M. Scheiman, and S. Sadeghi Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies Am J Gastroenterol 106 2011 254 260
16. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831 (Pubitemid 29142625)